Meadow Creek Investment Management’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-9,688
Closed -$56K 1378
2019
Q1
$56K Hold
9,688
﹤0.01% 1262
2018
Q4
$130K Buy
9,688
+1,568
+19% +$26.4K ﹤0.01% 1093
2018
Q3
$158K Buy
8,120
+2,772
+52% +$59K ﹤0.01% 1145
2018
Q2
$137K Buy
5,348
+56
+1% +$1.31K ﹤0.01% 1114
2018
Q1
$107K Buy
+5,292
New +$123K ﹤0.01% 1189
2017
Q1
Sell
-1,400
Closed -$18K 1320
2016
Q4
$18K Buy
+1,400
New +$26.1K ﹤0.01% 1250

Other funds holding DPLO

Meadow Creek Investment Management's DPLO Position: Q2 2019 in Review

Meadow Creek Investment Management sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q2 2019, closing a stake of 9,688 shares — an estimated $56K sold.

Meadow Creek Investment Management first reported a position in DPLO in Q4 2016 and held it in 6 quarters. The position peaked at $158K in Q3 2018. 131 funds tracked by Wall St. Rank hold DPLO as of Q2 2019.

  • Meadow Creek Investment Management reported no remaining DIPLOMAT PHARMACY, INC. position as of Q2 2019 after selling out during the quarter.
  • Meadow Creek Investment Management sold 9,688 DIPLOMAT PHARMACY, INC. shares in Q2 2019, an estimated $56K.
  • Meadow Creek Investment Management first reported a position in DIPLOMAT PHARMACY, INC. in Q4 2016 and held it in 6 quarters.
  • Meadow Creek Investment Management's DIPLOMAT PHARMACY, INC. position peaked at $158K in Q3 2018.
  • 131 funds tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q2 2019.

Based on Meadow Creek Investment Management's 13F filing for Q2 2019, filed 13 Aug 2019.